Dapagliflozin 10 mg | GLIDAPAFLOZIN 10

Dapagliflozin 10mg belongs to the SGLT2 inhibitor class of medications, one of the most significant therapeutic advances in cardiometabolic medicine in recent years. Originally developed as an antidiabetic agent, dapagliflozin's clinical role has expanded considerably as large-scale clinical trials have revealed benefits extending well beyond blood glucose control, into heart failure management and chronic kidney disease protection.

Under the brand name Glidapaflozin 10, manufactured by Steris Healthcare, this formulation is prescribed by physicians, endocrinologists, cardiologists, and nephrologists across India, reflecting the genuinely multidisciplinary relevance this molecule has earned in modern clinical practice.

Product Information

Why It's Important

Few medication classes introduced in the last two decades have reshaped clinical practice as significantly as SGLT2 inhibitors, and dapagliflozin stands among the most extensively studied agents in this class. Its clinical importance today extends well beyond glycemic control, reflecting a body of large-scale outcome trial evidence that has fundamentally changed how physicians think about managing overlapping diabetes, cardiovascular disease, and kidney disease — three conditions that frequently coexist in the same patient, particularly in India's aging and increasingly metabolically burdened population.

For Type 2 Diabetes management, dapagliflozin offers an insulin-independent mechanism of glucose control, meaning its efficacy does not rely on the pancreas's residual insulin-secreting capacity — a meaningful advantage as diabetes progresses over time and beta-cell function naturally declines. But dapagliflozin's significance has grown considerably further with the demonstration, across major cardiovascular and renal outcome trials, that it meaningfully reduces the risk of heart failure hospitalization and slows the progression of chronic kidney disease — benefits observed even in patients without diabetes.

This dual cardiorenal protective profile is particularly important in India, where heart failure and chronic kidney disease represent enormous and growing public health burdens, frequently intertwined with the country's rising diabetes prevalence. Having a single, well-tolerated oral medication capable of addressing glycemic control, cardiovascular risk, and renal protection simultaneously represents a genuinely efficient and clinically powerful tool for physicians managing complex, multi-morbid patients.

Key Benefits 

What Are the Benefits of Glidapaflozin 10?

Dapagliflozin 10mg, as formulated in Glidapaflozin 10, offers several clinically meaningful advantages:

• Insulin-independent glucose control: By working through the kidneys rather than relying on insulin secretion or action, dapagliflozin remains effective even as Type 2 Diabetes progresses and pancreatic function declines.
• Demonstrated heart failure benefit: Landmark clinical trials have shown that dapagliflozin significantly reduces the risk of heart failure hospitalization and cardiovascular death, in both diabetic and non-diabetic patients with heart failure with reduced ejection fraction.
• Chronic kidney disease protection: Dedicated renal outcome trials have demonstrated that dapagliflozin slows the progression of chronic kidney disease and reduces the risk of kidney failure, independent of diabetes status.
• Low hypoglycemia risk: Because its glucose-lowering mechanism is insulin-independent, dapagliflozin carries a comparatively low intrinsic risk of hypoglycemia when used without insulin or sulfonylureas.
• Modest weight reduction: The loss of glucose and associated calories through urine is often accompanied by modest but clinically meaningful weight reduction, particularly valuable for overweight Type 2 diabetic patients.
• Blood pressure benefit: Dapagliflozin's mild diuretic-like effect contributes to modest reductions in blood pressure, offering an additional benefit for many patients who also have hypertension.
• Convenient once-daily oral dosing: Simple, once-daily administration supports ease of use and improved long-term treatment adherence.
• Trusted manufacturing standards: Glidapaflozin 10 is manufactured by Steris Healthcare, a WHO-GMP and ISO 9001:2018 certified pharmaceutical company, ensuring consistent potency and reliable quality across every batch.

Side Effects 

Common side effects associated with Dapagliflozin 10mg include:

• Urinary tract infections, due to increased glucose concentration in urine
• Genital fungal infections (such as vaginal or penile yeast infections), also related to glucosuria
• Increased urination frequency
• Mild dizziness, particularly related to fluid shifts in the early weeks of treatment
• Headache
• Nasopharyngitis (common cold-like symptoms)
• Mild joint pain
• Back pain

Most of these effects are mild to moderate and tend to be manageable with adequate hydration and genital hygiene practices.

Precautions & Warnings

Before starting Glidapaflozin 10, patients and prescribers should consider the following precautions:

• Renal Impairment: Dapagliflozin's glucose-lowering efficacy decreases with declining kidney function, and use should be carefully assessed in patients with moderate to severe renal impairment, though it may still be used for cardiorenal protection at physician discretion within appropriate limits.
• Volume Depletion: Patients who are elderly, on diuretics, or have low blood pressure should be monitored for signs of dehydration or hypotension, particularly during treatment initiation.
• Genital and Urinary Infections: Patients should be counseled on genital hygiene practices to reduce the risk of fungal and urinary tract infections associated with glucosuria.
• Diabetic Ketoacidosis Risk: Patients should be aware of the signs of ketoacidosis and should temporarily discontinue therapy and seek medical advice during acute illness, surgery, or significantly reduced food/fluid intake ("sick day rules").
• Peripheral Vascular Disease: Caution is advised in patients with a history of peripheral vascular disease or foot ulceration, given observed amputation risk signals with some SGLT2 inhibitors; regular foot care and monitoring are recommended.
• Pregnancy and Lactation: This medication is generally not recommended during pregnancy or breastfeeding; alternative diabetes or heart failure management should be discussed with the treating physician.
• Bladder Cancer History: Caution is advised in patients with a history of bladder cancer, and this should be discussed with the prescribing physician.
• Surgery: Temporary discontinuation is often advised before major surgical procedures, as directed by the treating physician.
• Drug Interactions: Caution is required when combining with diuretics and other antihyperglycemic agents, due to potential additive effects on volume status and blood glucose.

Mechanism of Action 

Glidapaflozin 10 exerts its therapeutic effects through selective inhibition of renal glucose reabsorption:

1. Inhibition of Renal Glucose Reabsorption: Dapagliflozin selectively inhibits the sodium-glucose co-transporter 2 (SGLT2) in the proximal renal tubule, which is responsible for the majority of glucose reabsorption from the kidney's filtrate.
2. Increased Urinary Glucose Excretion: By blocking SGLT2, dapagliflozin causes excess glucose to be excreted in urine rather than reabsorbed into the bloodstream, lowering blood glucose levels independent of insulin secretion or action.
3. Osmotic Diuresis and Natriuresis: The glucose excretion is accompanied by mild osmotic diuresis and sodium excretion, contributing to modest reductions in blood pressure and fluid volume — a mechanism believed to play a role in dapagliflozin's heart failure benefit.
4. Reduced Intraglomerular Pressure: In the kidney, dapagliflozin is believed to reduce pressure within the glomerulus (the kidney's filtering unit), a mechanism thought to underlie its renal protective effects independent of glucose lowering.
5. Metabolic and Cardiac Effects: Additional proposed mechanisms contributing to dapagliflozin's cardiovascular benefit include improved cardiac energy metabolism, reduced cardiac preload and afterload, and favorable effects on cardiac remodeling, though the complete picture of these cardioprotective mechanisms continues to be studied.

This combination of insulin-independent glucose control alongside distinct cardiac and renal protective mechanisms is what has established dapagliflozin as a genuinely multi-system therapeutic agent, rather than a glucose-lowering medication alone.

Frequently Asked Questions 

1. Where can I buy Dapagliflozin 10 mg online?
You can purchase Dapagliflozin 10 mg through licensed online pharmacies or authorized pharmaceutical suppliers. Verify the manufacturer, strength, batch number, expiry date, and packaging before purchasing.

2. What is the price of Dapagliflozin 10 mg?
The price of Dapagliflozin 10 mg may vary depending on the brand, manufacturer, pack size, seller, and applicable pharmacy charges. Check the current listed price before ordering.

3. Can I order Dapagliflozin 10 mg online?
Yes, Dapagliflozin 10 mg can be ordered online where legally available. Since it is a prescription medicine, purchase it through a licensed pharmacy and provide a valid prescription when required.

4. Is Dapagliflozin 10 mg available from Steris Healthcare?
Availability depends on Steris Healthcare's current product range and stock status. Contact Steris Healthcare or an authorized distributor to confirm availability, strength, pack size, and ordering details.

5. What is Dapagliflozin 10 mg used for?
Dapagliflozin 10 mg is an SGLT2 inhibitor used to help manage type 2 diabetes mellitus. It may also be prescribed for certain adults with heart failure or chronic kidney disease, depending on the patient's condition and medical guidance.

6. What is the composition of Dapagliflozin 10 mg?
Dapagliflozin 10 mg contains Dapagliflozin 10 mg as the active pharmaceutical ingredient. The inactive ingredients may vary depending on the manufacturer and formulation.

7. Is a prescription required?
Yes, Dapagliflozin 10 mg is generally a prescription medicine and should be used under the supervision of a qualified healthcare professional.

8. How should Dapagliflozin 10 mg be taken?
Take Dapagliflozin 10 mg exactly as prescribed by your doctor. It is usually taken once daily, with or without food, at approximately the same time each day. Do not change the dose or stop treatment without medical advice.

9. What should I know before buying Dapagliflozin 10 mg?
Before purchasing, verify the strength, manufacturer, batch number, expiry date, packaging, and storage instructions. Inform your doctor about kidney or liver problems, dehydration, low blood pressure, diabetes medicines, pregnancy or breastfeeding, and other medicines you take.

10. How can I order Dapagliflozin 10 mg online?
Order Dapagliflozin 10 mg through a licensed online pharmacy or authorized pharmaceutical supplier. Provide a valid prescription if required, select the prescribed strength and pack size, and verify the product and delivery details before completing your purchase.